Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment | PLOS ONE
C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells | BMC Cancer | Full Text
BT-474 Tam2 - CRL-3434 | ATCC
Livin participates in resistance to trastuzumab therapy for breast cancer through ERK1/2 and AKT pathways and promotes EMT-like phenotype - RSC Advances (RSC Publishing) DOI:10.1039/C8RA05727C
Human Breast Carcinoma, ductal cell line BT-474-BHC11100222
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients | PNAS
BT-474 - HTB-20 | ATCC
Human Breast Carcinoma, ductal cell line BT-474-BHC11100222
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation | Breast Cancer Research | Full Text
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation | Nature Communications
CIMB | Free Full-Text | In Vitro Evidence of Differential Immunoregulatory Response between MDA-MB-231 and BT-474 Breast Cancer Cells Induced by Bone Marrow-Derived Mesenchymal Stromal Cells Conditioned Medium
Tumorsphere Culture of Human Breast Cancer Cell Lines
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
.jpg "Buy BT-474 | Cell Lines | CLS.shop")
Buy BT-474 | Cell Lines | CLS.shop
Conditioned media from MCF7 and BT474 breast cancer cells induce insulin resistance in skeletal muscle myotubes. Mona S. Alia, X
Conditioned media from MCF7 and BT474 breast cancer cells induce insulin resistance in skeletal muscle myotubes | bioRxiv
.jpg "Buy BT-474 | Cell Lines | CLS.shop")
Buy BT-474 | Cell Lines | CLS.shop
The morphologies of BT-474 cells preincubated with ( A ) Culture... | Download Scientific Diagram
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer | Breast Cancer Research | Full Text
